Compare Sterling Biotech with NEULAND LABS - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs NEULAND LABS - Comparison Results

STERLING BIOTECH     Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STERLING BIOTECH NEULAND LABS STERLING BIOTECH/
NEULAND LABS
 
P/E (TTM) x -0.4 57.0 - View Chart
P/BV x 0.0 4.3 0.3% View Chart
Dividend Yield % 0.0 0.1 -  

Financials

 STERLING BIOTECH   NEULAND LABS
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
NEULAND LABS
Mar-20
STERLING BIOTECH/
NEULAND LABS
5-Yr Chart
Click to enlarge
High Rs11754 1.4%   
Low Rs3247 1.4%   
Sales per share (Unadj.) Rs26.8594.5 4.5%  
Earnings per share (Unadj.) Rs-15.012.6 -118.4%  
Cash flow per share (Unadj.) Rs-5.537.0 -14.8%  
Dividends per share (Unadj.) Rs02.00 0.0%  
Dividend yield (eoy) %00.4 0.0%  
Book value per share (Unadj.) Rs54.9553.4 9.9%  
Shares outstanding (eoy) m267.8712.83 2,087.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.30.8 30.8%   
Avg P/E ratio x-0.539.6 -1.2%  
P/CF ratio (eoy) x-1.313.5 -9.4%  
Price / Book Value ratio x0.10.9 14.0%  
Dividend payout %015.8 0.0%   
Avg Mkt Cap Rs m1,8626,421 29.0%   
No. of employees `0001.41.3 105.6%   
Total wages/salary Rs m5471,236 44.3%   
Avg. sales/employee Rs Th5,303.35,949.4 89.1%   
Avg. wages/employee Rs Th403.8963.8 41.9%   
Avg. net profit/employee Rs Th-2,959.0126.4 -2,340.5%   
INCOME DATA
Net Sales Rs m7,1817,627 94.1%  
Other income Rs m4339 109.7%   
Total revenues Rs m7,2237,666 94.2%   
Gross profit Rs m9471,019 92.9%  
Depreciation Rs m2,543313 813.0%   
Interest Rs m4,377216 2,029.0%   
Profit before tax Rs m-5,931529 -1,120.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,924367 -524.2%   
Profit after tax Rs m-4,007162 -2,471.9%  
Gross profit margin %13.213.4 98.7%  
Effective tax rate %32.469.4 46.8%   
Net profit margin %-55.82.1 -2,625.6%  
BALANCE SHEET DATA
Current assets Rs m14,3355,152 278.2%   
Current liabilities Rs m49,8093,576 1,392.7%   
Net working cap to sales %-494.020.7 -2,391.6%  
Current ratio x0.31.4 20.0%  
Inventory Days Days403105 383.9%  
Debtors Days Days17191 187.8%  
Net fixed assets Rs m55,4323,969 1,396.8%   
Share capital Rs m268129 207.7%   
"Free" reserves Rs m13,9356,971 199.9%   
Net worth Rs m14,7017,100 207.1%   
Long term debt Rs m9,478774 1,225.0%   
Total assets Rs m73,98812,310 601.1%  
Interest coverage x-0.43.5 -10.3%   
Debt to equity ratio x0.60.1 591.6%  
Sales to assets ratio x0.10.6 15.7%   
Return on assets %0.53.1 16.3%  
Return on equity %-27.32.3 -1,193.8%  
Return on capital %-6.49.5 -67.9%  
Exports to sales %25.90-   
Imports to sales %0.20-   
Exports (fob) Rs m1,860NA-   
Imports (cif) Rs m12NA-   
Fx inflow Rs m1,8605,187 35.9%   
Fx outflow Rs m251,593 1.6%   
Net fx Rs m1,8353,594 51.1%   
CASH FLOW
From Operations Rs m1,719573 299.7%  
From Investments Rs m-3,148-487 646.7%  
From Financial Activity Rs m1,426-55 -2,602.2%  
Net Cashflow Rs m-333 -10.4%  

Share Holding

Indian Promoters % 33.9 36.3 93.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 63.7 -  
FIIs % 9.9 0.0 -  
ADR/GDR % 16.9 0.0 -  
Free float % 39.3 63.7 61.7%  
Shareholders   21,482 12,705 169.1%  
Pledged promoter(s) holding % 55.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STERLING BIOTECH With:   CADILA HEALTHCARE  TTK HEALTHCARE  ORCHID PHARMA  BIOCON   J.B.CHEMICALS  

Compare STERLING BIOTECH With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 154 Points Lower, Nifty Ends at 14,834; Bajaj Finance and UPL Among Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended marginally lower.

Related Views on News

NEULAND LABS Announces Quarterly Results (3QFY21); Net Profit Up 141.5% (Quarterly Result Update)

Feb 3, 2021 | Updated on Feb 3, 2021

For the quarter ended December 2020, NEULAND LABS has posted a net profit of Rs 267 m (up 141.5% YoY). Sales on the other hand came in at Rs 2 bn (up 20.5% YoY). Read on for a complete analysis of NEULAND LABS's quarterly results.

NEULAND LABS 2019-20 Annual Report Analysis (Annual Result Update)

Sep 2, 2020 | Updated on Sep 2, 2020

Here's an analysis of the annual report of NEULAND LABS for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of NEULAND LABS. Also includes updates on the valuation of NEULAND LABS.

More Views on News

Most Popular

A Critical Update on the Market(Fast Profits Daily)

Mar 30, 2021

In this video, I'll tell you why I am recommending caution in the market at this time.

My Recent Recommendation Will Profit from the Global Supply Chain Crisis(Profit Hunter)

Mar 31, 2021

A tiny chemical company, started in the Licence Raj era, is a great example of a new wealth creating opportunity.

My Stock Trading Strategy(Fast Profits Daily)

Mar 31, 2021

In this video I'll show you exactly how I go about picking stocks for trading.

What You Need to Find Hundred Baggers(Profit Hunter)

Mar 30, 2021

100 baggers of the last decade share this common trait. Here's how to use it to nail future multibaggers.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Nov 5, 2018 (Close)

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH - TTK HEALTHCARE COMPARISON

COMPARE STERLING BIOTECH WITH

MARKET STATS